We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMBM
3151
DELISTED
Cambium Networks
CMBM
$99K ﹤0.01%
5,843
+4,626
+380% +$60.7K
RJET
3152
Republic Airways Holdings
RJET
$952M
$99K ﹤0.01%
2,239
+1,817
+431% +$92.5K
VIVS
3153
VivoSim Labs
VIVS
$1.14M
$99K ﹤0.01%
1,038
+867
+507% +$112K
JOBS
3154
DELISTED
51job Inc
JOBS
$99K ﹤0.01%
1,277
-979
-43% -$68K
TLND
3155
DELISTED
Talend S.A. American Depositary Shares
TLND
$99K ﹤0.01%
+2,532
New +$98K
FNWB icon
3156
First Northwest Bancorp
FNWB
$110M
$98K ﹤0.01%
9,916
+6,840
+222% +$78.2K
IJR icon
3157
iShares Core S&P Small-Cap ETF
IJR
$113B
$98K ﹤0.01%
1,397
-53,964
-97% -$3.87M
LVO icon
3158
LiveOne
LVO
$56.8M
$98K ﹤0.01%
3,764
+3,050
+427% +$95.4K
MNSB icon
3159
MainStreet Bancshares
MNSB
$176M
$98K ﹤0.01%
8,022
+5,843
+268% +$76.8K
NTRA icon
3160
Natera
NTRA
$44.7B
$98K ﹤0.01%
1,359
-3,638
-73% -$207K
OVBC icon
3161
Ohio Valley Banc Corp
OVBC
$214M
$98K ﹤0.01%
4,728
+2,785
+143% +$60.4K
NGM
3162
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$98K ﹤0.01%
6,190
+2,276
+58% +$41.5K
BPOP icon
3163
Popular Inc
BPOP
$11.3B
$97K ﹤0.01%
2,678
-3,345
-56% -$124K
EARN
3164
Ellington Residential Mortgage REIT
EARN
$165M
$97K ﹤0.01%
8,737
+1,187
+16% +$13K
FBRX icon
3165
Forte Biosciences
FBRX
$1.57B
$97K ﹤0.01%
80
+46
+135% +$30.5K
MHK icon
3166
Mohawk Industries
MHK
$9.44B
$97K ﹤0.01%
992
+176
+22% +$15.8K
UBS icon
3167
UBS Group
UBS
$176B
$97K ﹤0.01%
8,666
+5,893
+213% +$70.6K
MFNC
3168
DELISTED
Mackinac Financial Corporation
MFNC
$97K ﹤0.01%
10,058
+8,424
+516% +$81.2K
STL
3169
DELISTED
Sterling Bancorp
STL
$97K ﹤0.01%
9,226
-36,295
-80% -$411K
CASI
3170
DELISTED
CASI Pharmaceuticals
CASI
$96K ﹤0.01%
6,281
+5,166
+463% +$97.3K
ELVN icon
3171
Enliven Therapeutics
ELVN
$4.3B
$96K ﹤0.01%
1,181
+981
+491% +$88.5K
ETNB
3172
DELISTED
89bio
ETNB
$96K ﹤0.01%
3,755
+993
+36% +$31.5K
EWT icon
3173
iShares MSCI Taiwan ETF
EWT
$11.5B
$96K ﹤0.01%
2,127
-4,659
-69% -$206K
FSFG
3174
DELISTED
First Savings Financial Group
FSFG
$96K ﹤0.01%
5,304
-336
-6% -$5.02K
MTN icon
3175
Vail Resorts
MTN
$5.3B
$96K ﹤0.01%
450
-622
-58% -$128K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.